home.aspx
 
. https://www.redchip.com/

Can-Fite Biopharma: $9 Price Target from Dawson James

video
SHARESHARESHARE
Can-Fite BioPharma Ltd. (NYSE American: CANF) is an advanced clinical stage drug development company with a platform technology that addresses multi-billion-dollar markets in the treatment of autoimmune inflammatory diseases including Rheumatoid Arthritis and Psoriasis, and liver diseases including advanced liver cancer and NASH.
FOR MORE INFORMATION, VISIT THE WEBSITE